Terms: = Prostate cancer AND NCOA1, RIP160, 8648, ENSG00000084676, NCoA-1, SRC1, MGC129719, MGC129720, F-SRC-1
90 results:
1. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.
Tong Z; Zhang Y; Guo P; Wang W; Chen Q; Jin J; Liu S; Yu C; Mo P; Zhang L; Huang J
J Cell Mol Med; 2024 Apr; 28(7):e18171. PubMed ID: 38506084
[TBL] [Abstract] [Full Text] [Related]
2. Androgen receptor cofactors: A potential role in understanding prostate cancer.
Li X; Xiong H; Mou X; Huang C; Thomas ER; Yu W; Jiang Y; Chen Y
Biomed Pharmacother; 2024 Apr; 173():116338. PubMed ID: 38417290
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression.
Pimenta R; Malulf FC; Romão P; Caetano GVB; da Silva KS; Ghazarian V; Dos Santos GA; Guimarães V; Silva IA; de Camargo JA; Recuero S; Melão BVLA; Antunes AA; Srougi M; Nahas W; Leite KRM; Reis ST
J Cancer Res Clin Oncol; 2024 Feb; 150(2):70. PubMed ID: 38305916
[TBL] [Abstract] [Full Text] [Related]
4. Androgen Receptor-Interacting Proteins in prostate cancer Development and Therapy Resistance.
Culig Z; Puhr M
Am J Pathol; 2024 Mar; 194(3):324-334. PubMed ID: 38104650
[TBL] [Abstract] [Full Text] [Related]
5. Joint analysis of WES and RNA-Seq identify signature genes related to metastasis in prostate cancer.
Xiang C; Li Y; Wang W; Tao H; Liang N; Wu S; Yu T; Cui X; Xie Y; Zuo H; Lin C; Xu F
J Cell Mol Med; 2023 Jul; 27(14):1947-1958. PubMed ID: 37378426
[TBL] [Abstract] [Full Text] [Related]
6. Intratumoral Restoration of miR-137 Plus Cholesterol Favors Homeostasis of the miR-137/Coactivator p160/AR Axis and Negatively Modulates Tumor Progression in Advanced prostate cancer.
Pimenta R; Mioshi CM; Gonçalves GL; Candido P; Camargo JA; Guimarães VR; Chiovatto C; Ghazarian V; Romão P; da Silva KS; Dos Santos GA; Silva IA; Srougi M; Nahas WC; Leite KR; Viana NI; Reis ST
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298588
[TBL] [Abstract] [Full Text] [Related]
7. Cholesterol Triggers Nuclear Co-Association of Androgen Receptor, p160 Steroid Coactivators, and p300/CBP-Associated Factor Leading to Androgenic Axis Transactivation in Castration-Resistant prostate cancer.
Pimenta R; Camargo JA; Candido P; Ghazarian V; Gonçalves GL; Guimarães VR; Romão P; Chiovatto C; Mioshi CM; Dos Santos GA; Silva IA; Birbrair A; Srougi M; Nahas WC; Leite KR; Viana NI; Reis ST
Cell Physiol Biochem; 2022 Dec; 56(S4):1-15. PubMed ID: 36458578
[TBL] [Abstract] [Full Text] [Related]
8. Simulated Microgravity Influences VEGF, MAPK, and PAM Signaling in prostate cancer Cells.
Hybel TE; Dietrichs D; Sahana J; Corydon TJ; Nassef MZ; Wehland M; Krüger M; Magnusson NE; Bauer J; Utpatel K; Infanger M; Grimm D; Kopp S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070055
[TBL] [Abstract] [Full Text] [Related]
9. In Vivo Effects of Polymerized Anthocyanin from Grape Skin on Benign Prostatic Hyperplasia.
Choi YJ; Fan M; Tang Y; Yang HP; Hwang JY; Kim EK
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31615010
[TBL] [Abstract] [Full Text] [Related]
10. Steroid receptor coactivator-1 regulates glioma angiogenesis through polyomavirus enhancer activator 3 signaling.
Zhang Y; Shi W
Biochem Cell Biol; 2019 Aug; 97(4):488-496. PubMed ID: 30532986
[TBL] [Abstract] [Full Text] [Related]
11. Role of P53-Senescence Induction in Suppression of LNCaP prostate cancer Growth by Cardiotonic Compound Bufalin.
Zhang Y; Dong Y; Melkus MW; Yin S; Tang SN; Jiang P; Pramanik K; Wu W; Kim S; Ye M; Hu H; Lu J; Jiang C
Mol Cancer Ther; 2018 Nov; 17(11):2341-2352. PubMed ID: 30166403
[TBL] [Abstract] [Full Text] [Related]
12. Studies on Steroid Receptor Coactivators in prostate cancer.
Culig Z; Santer FR
Methods Mol Biol; 2018; 1786():259-262. PubMed ID: 29786798
[TBL] [Abstract] [Full Text] [Related]
13. Targeting AR Variant-Coactivator Interactions to Exploit prostate cancer Vulnerabilities.
Magani F; Peacock SO; Rice MA; Martinez MJ; Greene AM; Magani PS; Lyles R; Weitz JR; Burnstein KL
Mol Cancer Res; 2017 Nov; 15(11):1469-1480. PubMed ID: 28811363
[TBL] [Abstract] [Full Text] [Related]
14. The co-regulators SRC-1 and SMRT are involved in interleukin-6-induced androgen receptor activation.
Wang Q; Wang H; Ju Q; Ding Z; Ge X; Shi QM; Zhou JL; Zhou XL; Zhang JP; Zhang MR; Yu HM; Xu LC
Eur Cytokine Netw; 2016 Nov; 27(4):108-113. PubMed ID: 28396297
[TBL] [Abstract] [Full Text] [Related]
15. The AR/ncoa1 axis regulates prostate cancer migration by involvement of PRKD1.
Luef B; Handle F; Kharaishvili G; Hager M; Rainer J; Janetschek G; Hruby S; Englberger C; Bouchal J; Santer FR; Culig Z
Endocr Relat Cancer; 2016 Jun; 23(6):495-508. PubMed ID: 27255895
[TBL] [Abstract] [Full Text] [Related]
16. Inhibition effect of cypermethrin mediated by co-regulators SRC-1 and SMRT in interleukin-6-induced androgen receptor activation.
Wang Q; Zhou JL; Wang H; Ju Q; Ding Z; Zhou XL; Ge X; Shi QM; Pan C; Zhang JP; Zhang MR; Yu HM; Xu LC
Chemosphere; 2016 Sep; 158():24-9. PubMed ID: 27239967
[TBL] [Abstract] [Full Text] [Related]
17. Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant prostate cancer.
Yang YC; Banuelos CA; Mawji NR; Wang J; Kato M; Haile S; McEwan IJ; Plymate S; Sadar MD
Clin Cancer Res; 2016 Sep; 22(17):4466-77. PubMed ID: 27140928
[TBL] [Abstract] [Full Text] [Related]
18. ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer.
Wang J; Zou JX; Xue X; Cai D; Zhang Y; Duan Z; Xiang Q; Yang JC; Louie MC; Borowsky AD; Gao AC; Evans CP; Lam KS; Xu J; Kung HJ; Evans RM; Xu Y; Chen HW
Nat Med; 2016 May; 22(5):488-96. PubMed ID: 27019329
[TBL] [Abstract] [Full Text] [Related]
19. Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat prostate cancer.
Foley C; Mitsiades N
Horm Cancer; 2016 Apr; 7(2):84-103. PubMed ID: 26728473
[TBL] [Abstract] [Full Text] [Related]
20. Bone stroma-derived cells change coregulators recruitment to androgen receptor and decrease cell proliferation in androgen-sensitive and castration-resistant prostate cancer cells.
Villagran MA; Gutierrez-Castro FA; Pantoja DF; Alarcon JC; Fariña MA; Amigo RF; Muñoz-Godoy NA; Pinilla MG; Peña EA; Gonzalez-Chavarria I; Toledo JR; Rivas CI; Vera JC; McNerney EM; Onate SA
Biochem Biophys Res Commun; 2015 Nov; 467(4):1039-45. PubMed ID: 26494300
[TBL] [Abstract] [Full Text] [Related]
[Next]
